PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Naloxone hydrochloride - Opioid overdose
PAD Profile : Naloxone hydrochloride - Opioid overdose
Keywords :
opioid reversal, opioid antidote, opioid poisoning, toxbase, CNS depression, community PGD
Traffic Light Status
Status 1 of 3.
Status :
Red
Important
Formulations :
- Intravenous injection (IV)
Important Information :
Please check TOXBASE for further information. https://www.toxbase.org/ . Intramuscular and intranasal preparations are available for use in non-medical settings
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 3.
Status :
Red
Important
Formulations :
- Nasal spray
Important Information :
May be given intranasally in non-medical settings.
See Healthy Surrey website for details on accessing naloxone nasal spray in the community https://www.healthysurrey.org.uk/drugs-and-alcohol/naloxone
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 3.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
11 February 2025
Surrey Heartlands Medicines Optimisation Board (MOB)
This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.
See “Formulary Status” to identify where this drug has been agreed for use.
Associated BNF Codes
19. Other Drugs and Preparations
19.02.07. Poisoning antidotes